FindTrial
Sign In

A study to compare the impact of guided Advance Care Planning discussions with Standard Care in patients with Advanced Cancers

Effectiveness of Facilitated Advanced Care Planning (ACP) Conversations versus Usual Care for Patients with Advanced Cancers. A Randomized controlled trial. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085302
Enrollment
170
Registered
2025-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C799- Secondary malignant neoplasm of unspecified site

Interventions

Intervention1: Facilitated Advanced Care Planning (ACP) conversations: Participants will undergo 2 3 structured sessions (approximately 60 90 minutes each) with trained facilitators to discuss their v

Sponsors

Dr Raghu S Thota
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients aged 18 years and above diagnosed with advanced cancer (stage III or IV). 2. Able to provide informed consent in English, Hindi or Marathi or have a legally authorized representative. 3. Expected to have a life expectancy of at least 3 months. 4. Willing to participate in ACP discussions and complete assessments. 5. Caregiver available to participate, if applicable.

Exclusion criteria

Exclusion criteria: 1. Cognitive impairment that prevents meaningful communication or decision-making. 2. Severe psychiatric disorders (e.g., active psychosis) interfering with participation. 3. Participation in another conflicting intervention trial. 4. Unstable medical conditions requiring immediate intensive care. 5. Patients who decline ACP conversations or follow-up participation.

Design outcomes

Primary

MeasureTime frame
To assess the impact of facilitated ACP conversations on the alignment of care with patient preferences compared to usual care.Timepoint: Baseline, 4th and 12th week and at 6 months or end of life—

Secondary

MeasureTime frame
To evaluate the effect of facilitated ACP on Psychological well-being (e.g., anxiety, depression). Timepoint: Baseline, 4th and 12th week and at 6 months or end of life ;To evaluate the effect of facilitated ACP on Quality of life.Timepoint: Baseline, 4th and 12th week and at 6 months or end of life;To evaluate the effect of facilitated ACP on Patient and family satisfaction with care and caregiver burden.Timepoint: Baseline, 4th and 12th week and at 6 months or end of life;To evaluate the effect of facilitated ACP on Frequency of hospitalizations and intensive care unit (ICU) admissionsTimepoint: Baseline, 4th and 12th week and at 6 months or end of life—

Countries

India

Contacts

Public ContactDr Raghu S Thota

Tata Memorial Hospital

ragstho24@rediffmail.com9769077764

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026